FDA 483 - FUJIFILM Diosynth Biotechnologies Texas, LLC - March 11, 2025

The provided document content was insufficient for a comprehensive summary. It appears to contain only page numbers without the actual text of the FDA Form 483 inspection report. Consequently, key details such as the company name, inspection dates, main violations or issues, applicable regulatory framework, and any required actions could not be extracted or synthesized. To generate an accurate and concise summary, the full text of the FDA 483 document, including detailed observations, is necessary.